The Department of Agriculture, Environment and Rural Affairs (DAERA) has removed a significant administrative hurdle for farmers battling Bluetongue Virus Serotype 3 (BTV-3), announcing that vaccination will now be permitted under a general licence rather than requiring individual applications. The change, announced on 15 April 2026, aims to simplify access to vaccines as Northern Ireland confronts an evolving disease situation that has already seen five confirmed cases of the midge-borne virus.
BTV-3 poses serious risks to livestock fertility and survival rates, causing symptoms ranging from fever and lameness to congenital defects and abortion in cattle and sheep. While the virus presents no threat to human health or food safety, it has already disrupted agricultural trade since Northern Ireland’s first confirmed case in late November 2025, prompting the suspension of the region’s disease-free status and restricting movements from Great Britain.
Streamlined Vaccination Process
Moving from a specific licence system to a general licence marks what officials describe as the “next phase” in disease management. Under the new arrangement, livestock keepers no longer need to apply for individual permits to vaccinate their animals, though strict conditions remain in place.
Vaccination still requires a veterinary prescription, and farmers must maintain accurate records complying with veterinary medicine recording requirements. The general licence covers vaccines currently authorised for use, though DAERA has not specified which particular products are included or detailed the costs farmers will face.
DAERA Minister Andrew Muir said: “The introduction of a general licence is a practical next step in the management of BTV‑3. By reducing the administrative burden, it will make it easier for farmers to access vaccines and make informed decisions to protect their animals.”
Disease Context and Current Restrictions
Bluetongue is a notifiable disease spread by biting midges, which are most active between April and November. The virus can replicate only when temperatures exceed 12°C, making the summer months particularly high-risk. Research indicates that BTV-3 can cause severe fertility impacts, including embryonic death and bull infertility, as well as decreased milk yields and increased mortality across all age groups.
According to surveillance data, there are currently five confirmed cases of BTV-3 in Northern Ireland. The first case was detected on 29 November 2025 at a premises outside Bangor, County Down, with the most recent confirmation coming in late March 2026. Across Great Britain, the situation is more severe, with 333 cases confirmed in the 2025-2026 season.
Key facts about the current situation:
- Cross-border movements of cattle and sheep for breeding and production resumed on 6 March 2026 following a temporary ban
- The Temporary Control Zone in County Down was lifted on the same date
- All animals within Northern Ireland are now free to move under a General Licence
- Movements of live animals from Great Britain to Northern Ireland remain suspended
- Farmers, veterinarians and laboratories must report any suspicion of bluetongue immediately to DAERA on 0300 200 7840
Mandatory Reporting and Safety Requirements
Despite the relaxed vaccination rules, strict reporting requirements remain in force. DAERA emphasised: “Bluetongue is a notifiable disease. Farmers, veterinarians and laboratories must continue to report any suspicion of bluetongue immediately to DAERA.” Failure to report suspected cases is an offence.
The department also reassured the public: “Bluetongue poses no risk to human health or food safety.” The virus affects only ruminants and camelids, with cattle often appearing healthy while carrying high levels of virus that can infect midges.
Unanswered Questions and Industry Concerns
While the general licence reduces paperwork, several practical concerns remain unaddressed in DAERA’s announcement. The department has not disclosed the cost of vaccination to farmers, nor has it indicated whether financial support will be available. In the Republic of Ireland, where vaccination is also being rolled out, costs have been estimated at approximately €9 per cattle dose and €4.50 per sheep dose, with farming associations calling for government subsidies.
Additionally, the announcement does not specify how many vaccine doses are available in Northern Ireland, though veterinary officers have previously indicated sufficient stock for 100,000 animals. With the high-risk summer period approaching, questions remain about whether supply can meet potential demand if uptake increases significantly under the simplified system.
The policy also raises questions about Northern Ireland’s path to regaining its suspended EU disease-free status, which affects export capabilities. The minimum period for disease-free status restoration is two years from the last positive case, meaning trade restrictions could persist well into 2027 regardless of vaccination progress.
Questions stakeholders may wish to consider:
- How will DAERA monitor vaccine supply to ensure availability matches increased demand under the general licence system?
- Will financial assistance be provided to farmers, particularly smaller producers, to cover vaccination costs?
- What coordination mechanisms exist with veterinary authorities in the Republic of Ireland to ensure consistent all-island disease management?
- How will the general licence affect Northern Ireland’s ability to demonstrate disease control to EU trading partners?
- What provisions are in place if the virus spreads beyond the current five confirmed cases during the high-risk summer months?
Next Steps for Livestock Keepers
Farmers wishing to vaccinate their animals should contact their private veterinary practitioner to discuss prescription options and obtain the general licence documentation from the DAERA website. They must also familiarise themselves with the Disease Control Framework, which outlines comprehensive response protocols.
As temperatures rise toward the summer peak, when midge activity intensifies, the effectiveness of this policy change will become apparent. The coming months will reveal whether streamlined access to vaccination can prevent the kind of widespread outbreaks seen across Great Britain, or whether Northern Ireland faces similar disruption to its agricultural sector.